BIT Capital’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAM
BIT Capital's RNAM Position: Q1 2026 in Review
BIT Capital sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 3,000 shares — an estimated $216K sold.
BIT Capital first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $216K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- BIT Capital reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- BIT Capital sold 3,000 Avidity Biosciences shares in Q1 2026, an estimated $216K.
- BIT Capital first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
- BIT Capital's Avidity Biosciences position peaked at $216K in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on BIT Capital's 13F filing for Q1 2026, filed 13 May 2026.